These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 36865405)
1. Dementia Risk Prediction in a Longitudinal Geriatric Parkinson's Disease Cohort: Evaluation and Application of the Montreal Parkinson Risk of Dementia Scale. Bohn L; McFall GP; Gee M; Postuma RB; Dixon RA; Camicioli R Can Geriatr J; 2023 Mar; 26(1):176-186. PubMed ID: 36865405 [TBL] [Abstract][Full Text] [Related]
2. Original research: initial development of a pragmatic tool to estimate cognitive decline risk focusing on potentially modifiable factors in Parkinson's disease. Carlisle TC; Medina LD; Holden SK Front Neurosci; 2023; 17():1278817. PubMed ID: 37942138 [TBL] [Abstract][Full Text] [Related]
3. Identifying key multi-modal predictors of incipient dementia in Parkinson's disease: a machine learning analysis and Tree SHAP interpretation. McFall GP; Bohn L; Gee M; Drouin SM; Fah H; Han W; Li L; Camicioli R; Dixon RA Front Aging Neurosci; 2023; 15():1124232. PubMed ID: 37455938 [TBL] [Abstract][Full Text] [Related]
4. Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease. Badrkhahan SZ; Sikaroodi H; Sharifi F; Kouti L; Noroozian M Appl Neuropsychol Adult; 2020; 27(5):431-439. PubMed ID: 30821505 [TBL] [Abstract][Full Text] [Related]
5. Neurocognitive speed and inconsistency in Parkinson's disease with and without incipient dementia: an 18-month prospective cohort study. de Frias CM; Dixon RA; Camicioli R J Int Neuropsychol Soc; 2012 Jul; 18(4):764-72. PubMed ID: 22621940 [TBL] [Abstract][Full Text] [Related]
6. Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease. Kandiah N; Zhang A; Cenina AR; Au WL; Nadkarni N; Tan LC Parkinsonism Relat Disord; 2014 Nov; 20(11):1145-8. PubMed ID: 25176439 [TBL] [Abstract][Full Text] [Related]
7. Reliability, validity, and diagnostic accuracy of Parkinson's Disease-Cognitive Rating Scale in Iranian patients with idiopathic Parkinson's disease. Mahmoudi Asl A; Mehdizadeh M; Kulisevsky J; Sabet A; Taghavi Azar Sharabiani P; Mehdizadeh H; Ashayeri H; Taghizadeh G Disabil Rehabil; 2022 May; 44(10):2091-2098. PubMed ID: 32924645 [TBL] [Abstract][Full Text] [Related]
8. Office-Based Screening for Dementia in Parkinson Disease: The Montreal Parkinson Risk of Dementia Scale in 4 Longitudinal Cohorts. Dawson BK; Fereshtehnejad SM; Anang JBM; Nomura T; Rios-Romenets S; Nakashima K; Gagnon JF; Postuma RB JAMA Neurol; 2018 Jun; 75(6):704-710. PubMed ID: 29582054 [TBL] [Abstract][Full Text] [Related]
9. Predictors of cognitive impairment in an early stage Parkinson's disease cohort. Hu MT; Szewczyk-Królikowski K; Tomlinson P; Nithi K; Rolinski M; Murray C; Talbot K; Ebmeier KP; Mackay CE; Ben-Shlomo Y Mov Disord; 2014 Mar; 29(3):351-9. PubMed ID: 24395708 [TBL] [Abstract][Full Text] [Related]
10. The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease. Brennan L; Siderowf A; Rubright JD; Rick J; Dahodwala N; Duda JE; Hurtig H; Stern M; Xie SX; Rennert L; Karlawish J; Shea JA; Trojanowski JQ; Weintraub D Parkinsonism Relat Disord; 2016 Apr; 25():21-6. PubMed ID: 26923524 [TBL] [Abstract][Full Text] [Related]